Companies:
50,705
Total Market Cap:
148170150319427.85
Scinai Immunotherapeutics Ltd.
NASDAQ: SCNI
Healthcare
Biotechnology
Global Rank
#47291
Country Rank
#565
Market Cap
2.03 M
Price
1.34
Change (%)
5.63%
Volume
49,761
Scinai Immunotherapeutics Ltd.'s latest marketcap:
2.03 M
As of 09/26/2025, Scinai Immunotherapeutics Ltd.'s market capitalization has reached $2.03 M. According to our data, Scinai Immunotherapeutics Ltd. is the 47291th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 2.03 M |
| Revenue (ttm) | 1.15 M |
| Net Income (ttm) | 347,000 |
| Shares Out | 1.51 M |
| EPS (ttm) | 0.26 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/05/2025 |
Market Cap Chart
Data Updated: 09/26/2025
Scinai Immunotherapeutics Ltd.'s yearly market capitalization.
Scinai Immunotherapeutics Ltd. has seen its market value drop from $11.2 M to $2.03 M since 2015, representing a total decrease of 81.88% and an annual compound decline rate (CAGR) of 16.09%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 09/26/2025 | $2.03 M | -31.03% | 47291 |
| 12/31/2024 | $2.9 M | 31.82% | 42441 |
| 12/29/2023 | $2.2 M | -60% | 41569 |
| 12/30/2022 | $5.5 M | -83.68% | 38003 |
| 12/31/2021 | $33.7 M | 5.64% | 29963 |
| 12/31/2020 | $31.9 M | -65.85% | 27200 |
| 12/31/2019 | $93.4 M | 199.36% | 18491 |
| 12/31/2018 | $31.2 M | 72.38% | 23442 |
| 12/29/2017 | $18.1 M | 60.18% | 25876 |
| 12/30/2016 | $11.3 M | 0.89% | 25001 |
Company Profile
Scinai Immunotherapeutics Ltd. was founded in 2003 in Israel.
on the Nasdaq Stock Market.
With 31 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Scinai Immunotherapeutics Ltd.'s (SCNI) current market cap?As of 09/26/2025, Scinai Immunotherapeutics Ltd. (including the parent company, if applicable) has an estimated market capitalization of $2.03 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Scinai Immunotherapeutics Ltd. (SCNI) rank globally by market cap?Scinai Immunotherapeutics Ltd. global market capitalization ranking is approximately 47291 as of 09/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.